Clinical Trial Update: Preclinical Studies of Omalizumab in Chronic Rhinosinusitis With Nasal Polyposis [EARLY_Phase 1]

View source ↗

Summary

This update summarizes early-phase studies of omalizumab for chronic rhinosinusitis with nasal polyps, with the trial status listed as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasal Polyps
• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• Omalizumab (Xolair) (omalizumab)

Snippet

Sponsor: Johns Hopkins University | Conditions: Chronic Rhinosinusitis With Nasal Polyps, Nasal Polyps | EARLY_Phase 1 | Status: COMPLETED